OncogenesisCancer BiologyPeer-reviewed journal article
Protein Tyrosine Phosphatase 4A3 (PTP4A3) modulates Src signaling in T-cell Acute Lymphoblastic Leukemia to promote leukemia migration and progression
Abstract
T-cell Acute Lymphoblastic Leukemia (T-ALL) is an aggressive blood cancer, and currently, there are no immunotherapies or molecularly targeted therapeutics available for treatment of this malignancy. The identification and characterization of genes and pathways that drive T-ALL progression is critical for development of new therapies for T-ALL. Here, we determined that Protein Tyrosine Phosphatase 4A3 (PTP4A3) plays a critical role in disease initiation and progression by promoting cell migration in T-ALL. PTP4A3 expression was upregulated in patient T-ALL samples at both the mRNA and protein levels compared to normal lymphocytes. Inhibition of PTP4A3 function with a small molecule inhibitor and knock-down of PTP4A3 expression using short-hairpin RNA (shRNA) in human T-ALL cells significantly impeded T-ALL cell migration capacity in vitro and reduced their ability to engraft and proliferate in vivo in xenograft mouse models. Additionally, PTP4A3 overexpression in a Myc-induced zebrafish T-ALL model significantly accelerated disease onset and shortened the time needed for cells to enter blood circulation. Reverse phase protein array (RPPA) revealed that manipulation of PTP4A3 expression levels in T-ALL cells directly affected the SRC signaling pathway, which plays a well-characterized role in migratory behavior of several cell types. Taken together, our study revealed that PTP4A3 is a key regulator of T-ALL migration via SRC signaling, and suggests that PTP4A3 plays an important role as an oncogenic driver in T-ALL.\n\nHighlightsO_LIA subset of T-cell Acute Lymphoblastic Leukemia (T-ALL) highly express the phosphatase PTP4A3\nC_LIO_LIPTP4A3 expression promotes leukemia development in zebrafish T-ALL models\nC_LIO_LILoss of PTP4A3 prevents T-ALL engraftment in mouse xenograft models\nC_LIO_LIKnock-down or small molecule inhibition of PTP4A3 prevents T-ALL migration in part via modulation of SRC signaling.\nC_LI
- organism: human
- organism: zebrafish
- assay: proteomics
- research focus: cancer & tumor microenvironment
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A screen of FDA-approved drugs identifies inhibitors of Protein Tyrosine Phosphatase 4A3 (PTP4A3 or PRL-3)
D. R. Rivas, M. V. C. Dela Cerna, … J. S. Blackburn·bioRxiv·May 24, 2020
- Cell-extrinsic effects in T cell acute lymphoblastic pre-leukemia stem cells mediated by EphA3
A. C. Pliego Zamora, H. Ranasinghe, … C. I. Slape·bioRxiv·Sep 14, 2020
- T-cell acute lymphoblastic leukemia progression is supported by inflammatory molecules including Hepatocyte Growth factor
Charly Le Maout, Lucine Fahy, … Vanessa Petit·Biomedicine & PharmacotherapyPeer-reviewed·Jul 1, 2024
- Integrin signaling is critical for myeloid-mediated support of T-cell acute lymphoblastic leukemia
A. Lyu, S. H. Nam, … L. I. R. Ehrlich·bioRxiv·Jan 5, 2022
- A novel retinoic acid analog, 4-Amino-2-Trifluoromethyl-Phenyl Retinate (ATPR) triggers differentiation and is effective in the treatment of Acute Promyelocytic Leukemia
Jing Bao, Yan Zhi Du, … Feihu Chen·bioRxiv·Jul 9, 2020
- NFAT are Essential and Redundant Actors for Leukemia Initiating Potential in T-cell Acute Lymphoblastic Leukemia
C. Catherinet, D. Passaro, … C. Tran Quang·bioRxiv·Oct 30, 2020